Fernando Luis Pagan MD

Movement Disorder

Vice Chairman of Neurology Professor of Neurology, Medstar Georgetown University Hospital Director of the Movement Disorders Program Translational Neurotherapeutics Program Georgetown University School of Medicine Medstar Georgetown University Hospital

Join to view full profile

1420 Beverly RoadSte 300McLean, VA 22101
Phone+1 202-295-0540
Fax+1 202-444-2661

Dr. Pagan is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Pagan's full profile Already have an account?

Education & Training

MedStar Health Georgetown UniversityResidency, Neurology, 1997 - 2000
MedStar Health Georgetown University/Georgetown HospitalResidency, Internal Medicine, 1996 - 1997
Georgetown University School of MedicineClass of 1996

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

DC State Medical License 1997 - 2026
VA State Medical License 2008 - 2026
American Board of Psychiatry and Neurology Neurology
National Board of Physicians and Surgeons Neurology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Centricity EMR, GE Healthcare, 2012, 2014, 2016-2017
CMS Meaningful Use Stage 2 Certification Centricity EMR, GE Healthcare, 2012, 2014, 2016-2017
CMS Meaningful Use Stage 2 Certification MEDSEEK Empower, SymphonyCare, LLC, 2012, 2014, 2016-2017

Clinical Trials

A Double Blind Placebo Controlled Trial Evaluating Rasagiline Effects on Cognition in Parkinson's Disease Patients With Mild Cognitive Impairment Receiving Dopaminergic Therapy
COMPLETED
PHASE4
Parkinson's Foundation Quality Improvement Initiative
COMPLETED
Myobloc Atrophy Study
COMPLETED
PHASE4

Publications & Presentations

PubMed

Underlying Tremor Improvement with Consistent Use of Transcutaneous Afferent Patterned Stimulation in Patients with Essential Tremor.
Stuart H Isaacson, Elizabeth Peckham, Winona Tse, Melita T Petrossian, Michael J Soileau
Tremor and Other Hyperkinetic Movements. 2026-01-01
Safety, tolerability and potential biomarkers of vodobatinib in patients with dementia with Lewy bodies.
Fernando L Pagan, Yasar Torres-Yaghi, Michaeline L Hebron, Barbara Wilmarth, Xiaoguang Liu
Parkinsonism & Related Disorders. 2025-11-01
4 citations
Safety, Cognitive, and Behavioral Outcomes in Patients with Dementia with Lewy Bodies Treated with Nilotinib.
Fernando Pagan, Yasar Torres-Yaghi, Michaeline Hebron, Barbara Wilmarth, R Scott Turner
Journal of Clinical Medicine. 2025-06-14

Press Mentions

Title:‘Give so Much That It Hurts:’ Bequest From Paul and Chandler Tagliabue Will Provide Funding for Georgetown Programs, Medical ResearchApril 29th, 2026
Cancer Drug Nilotinib Could Treat Parkinson's Disease and Restore Movement in Patients, Finds StudyDecember 25th, 2019
Nilotinib Appears Safe in Parkinson’s Trial; Drug Thought to Allow Dopamine ReplenishmentDecember 17th, 2019